Emerging therapies are reshaping schizophrenia care by introducing novel mechanisms that extend beyond traditional dopamine receptor blockade. Listen in to learn from Dr Leslie Citrome about evolving concepts in schizophrenia neurobiology; the clinical evidence supporting emerging therapeutic approaches with a focus on muscarinic-targeted therapies; and practical strategies for translating these advances into patient care, including treatment selection, safety, and tolerability considerations.

Presenter:
Leslie Citrome, MD, MPH

Link to full program:
https://bit.ly/4gvLZYm

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Neuroscience Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Novel C5 inhibitors are reshaping individualized care for generalized myasthenia gravis. Listen in to learn from Drs Muppidi, Narayanaswami, Kaminski, and Paul about persistent needs in gMG care, clinical differences among C5 inhibitors, and practical considerations for matching treatment decisions to patient goals, access, safety, and long-term adherence.

Presenters:

Srikanth Muppidi, MD

Pushpa Narayanaswami, MD, FAAN

Henry J. Kaminski, MD

Pritikanta Paul, MD

Link to full program: 
https://bit.ly/4aXq3Ce

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Neuroscience Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Multiple sclerosis care is evolving fast, from what current AAN guidance emphasizes to what’s emerging in the treatment pipeline. In this episode, Patricia K. Coyle, MD, FAAN, FANA, reviews practical, patient-centered principles for MS management, including shared decision-making, realistic expectations, adherence, monitoring, and optimizing comorbidities and lifestyle factors. She also explains when to reassess and potentially switch therapy based on relapses, disability progression, and MRI activity, and highlights pipeline advances such as CNS-penetrant BTK inhibitors and other investigational approaches.

Presenters:
Patricia K. Coyle, MD, FAAN, FANA

Link to full program:
https://bit.ly/4dhvLAL

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Neuroscience Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Wondering what is coming next in MS care beyond today’s disease-modifying therapies? This episode spotlights CNS-penetrant oral BTK inhibitors and the fast-moving pipeline targeting neuroinflammation, immune reset, and future CNS repair, then brings it to life with a real patient case that tests treatment selection and the decision to switch therapy. Led by Patricia K. Coyle, MD, FAAN, FANA, it is a practical listen for healthcare professionals who want a clear sense of where MS treatment is heading and why it matters now.

Presenters:

Patricia K. Coyle, MD, FAAN, FANA

Link to full program:
https://bit.ly/4sau7px

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Neuroscience Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Multiple sclerosis (MS) is increasingly understood as a spectrum in which relapsing activity and progression can overlap, creating a need for smart, individualized use of disease-modifying therapies. Listen in to learn from Patricia K. Coyle, MD, FAAN, FANA, for a practical review of today’s MS DMT options, with a focus on high-efficacy monoclonal antibodies such as anti-CD20 therapies, how healthcare professionals think about progression concepts like PIRA and RAW, and what emerging trial designs like OCTOPUS may mean for improving treatment options in progressive MS.

Presenter:

Patricia K. Coyle, MD, FAAN, FANA

Link to full program:
https://bit.ly/3PdRks4

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Neuroscience Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this podcast episode, Dr Jonathan Meyer answers additional questions from learners at our Psychopharmacology Update conference. Questions explore other disease states where psychosis can occur, practical considerations around special populations, tolerability, drug combinations, and the potential future of muscarinic-based therapies. For additional activities in this program including a ClinicalThought commentary, a CME/CE/CPE certified on-demand webcast and a downloadable slideset, go to: https://bit.ly/4qjcYcj

Faculty:

Jonathan M. Meyer, MD, DLFAPA
Voluntary Clinical Professor of Psychiatry
University of California, San Diego
Senior Academic Adviser
California Department of State Hospitals
San Diego, California

Get access to all of our new podcasts by subscribing to the CCO Neuroscience Podcast on Apple Podcasts, YouTube Podcasts, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode of “Cognitive Conversations,” expert faculty discuss breaking data presentations from the 2026 Clinical Trials on Alzheimer’s Disease conference held in San Diego, California, from December 1-4, 2025, and their implications for clinical practice.

Topics covered include:

• Evoke and evoke+ phase III trials of semaglutide
• Subcutaneous lecanemab as initiation and maintenance treatment
• Blood-based biomarker assays
• Trontinemab and other brain shuttles
• Tau targeting therapies in development
• Preventive impact of BCG and herpes zoster vaccination

This podcast episode is part of the CME/CE-accredited program, “Early Clues, Lasting Impact: Detecting and Treating Alzheimer’s Disease in Its Earliest Stages,” supported by an educational grant from Novo Nordisk. 

Faculty:

Anton P. Porsteinsson, MD 
William B. and Sheila Konar Professor of Psychiatry, Neurology, and Neuroscience, and Medicine
Director, Alzheimer's Disease Care, Research and Education Program (AD-CARE)
University of Rochester School of Medicine and Dentistry
Rochester, New York

Vijay K. Ramanan, MD, PhD
Consultant and Associate Professor
Director, Alzheimer’s Disease Treatment Clinic
Department of Neurology
Mayo Clinic
Rochester, Minnesota 

Link to obtain CME/CE credit: 
https://bit.ly/4999otE

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this podcast episode, epilepsy specialists Danielle Becker, MD, MS, FAES, and Sarah Weatherspoon, MD, discuss the personalization of the most recently available epilepsy rescue treatments for younger kids and their implementation by the patient care team.

Faculty:

Danielle Becker, MD, MS, FAES 
Division Director of Epilepsy
Associate Professor of Neurology
The Ohio State University Wexner Medical Center
Columbus, Ohio 

Sarah Weatherspoon, MD
Associate Chief of Child Neurology
Tuberous Sclerosis Center of Excellence, Neurology Co-Director
Le Bonheur Children's Hospital
University of Tennessee Health Science Center
Memphis, Tennessee

Resources mentioned in this episode:

• Epilepsy Foundation Seizure Action Plan Toolkit
• CDC Managing Epilepsy Well (MEW) Network

Link to Brain Health Hub with additional educational activities: 
https://bit.ly/3Y12Isx

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Alireza Atri, MD, PhD, discusses his approach to patient conversations on brain health and provides advice to healthcare professionals practicing in community neurology settings, in a dialogue with Robin Martinez, a patient advocate from the Smart Patients online community. Supported by an educational grant from Lilly.

Faculty:

Alireza Atri, MD, PhD 
Chief Medical Officer, Banner Research
Phoenix, Tucson and Sun City, Arizona
Director, Banner Sun Health Research Institute
Sun City, Arizona

Robin Martinez
Patient Advocate
Coordinator of Online Communities
Website Administration
Smart Patients Inc.
Denver, Colorado

Resources mentioned in this episode:

• Alzheimer’s Association: DETeCD-ADRD Clinical Practice Guidelines for Specialty Care 
  https://bit.ly/4kqtYt5
• American Geriatrics Society: 2023 Beers Criteria for Potentially Inappropriate Medication Use in Older Adults 
  https://bit.ly/44zN8qG
• MoCA (Montreal Cognitive Assessment) : [Link to: https://mocacognition.com/]

Link to obtain CME/CE credit: 
https://bit.ly/44khuP5

Link to Brain Health Hub with additional educational activities:
https://bit.ly/4kziu6T

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, dementia expert Anton Porsteinsson, MD, discusses his approach to conversations on brain health with patients and provides guidance for HCPs practicing in community psychiatry settings, in a dialogue with Robin Martinez, a patient advocate from the Smart Patients online community. Supported by an educational grant from Lilly.

Faculty:

Anton P. Porsteinsson, MD 
William B. and Sheila Konar Professor of Psychiatry, Neurology, Neuroscience, and Medicine
Director, Alzheimer’s Disease Care, Research and Education Program (AD-CARE)
University of Rochester School of Medicine and Dentistry
Rochester, New York

Robin Martinez
Patient Advocate
Coordinator of Online Communities
Website Administration
Smart Patients Inc.
Denver, Colorado

Resources mentioned in this episode:

• Mini Mental State Examination (MMSE) [Link to: https://www.psychdb.com/_media/mmse.]
• Mini-Cog (quick dementia screening test) [Link to: https://mini-cog.com/]
• MoCA (Montreal Cognitive Assessment) : [Link to: https://mocacognition.com/]
• Alzheimer’s Association Local Chapters [Link to:https://www.alz.org/chapter-search]
• Local Department of Aging [Link to : https://www.thecountyoffice.com/department-of-aging/]

Link to obtain CME/CE credit: 
https://bit.ly/3IAbyc7

Link to Brain Health Hub with additional educational activities: 
https://bit.ly/40Jgth4

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.